LY 267108

Product Name: LY 267108
CAS No.: 105882-69-7
Chemical Name: LY 267108
Synonyms: LY 267108;Erythromycin Imp F;Erythromycin impurity 06;NMIWBQUQCOMGHJ-XWVSLMRSSA-N;Erythromycin Ethyl succinate Impurity F;Pseudo erythromycin A enol ether, EvoPure;8,9-Anhydropseudo-erythroMycin A-6,9-heMiketal;Erythromycin Impurity 15(Erythromycin EP Impurity F);Erythromycin Impurit F:(pseudoerythromycin A enol ether);Erythromycin EP Impurity F (Pseudo Erythromycin A Enol Ether)
CBNumber: CB71348120
Molecular Formula: C37H65NO12
Formula Weight: 715.91
MOL File: 105882-69-7.mol

More

Less

LY 267108 Property

Melting point:: 127.0-130.0 °C
Boiling point:: 810.7±65.0 °C(Predicted)
Density: 1.20±0.1 g/cm3(Predicted)
storage temp.: −20°C
solubility: DMF: Soluble; DMSO: Soluble; Ethanol: Soluble; Methanol: Soluble
pka: 13.45±0.70(Predicted)

More

Less

Safety

WGK Germany: 3

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

Sigma-Aldrich

Product number: 38874
Product name: Pseudoerythromycin A enol ether
Purity: analytical standard
Packaging: 5mg
Price: $639
Updated: 2024/03/01

Cayman Chemical

Product number: 15508
Product name: Pseudoerythromycin A enol ether
Purity: ≥98%
Packaging: 1mg
Price: $98
Updated: 2024/03/01

Cayman Chemical

Product number: 15508
Product name: Pseudoerythromycin A enol ether
Purity: ≥98%
Packaging: 5mg
Price: $294
Updated: 2024/03/01

American Custom Chemicals Corporation

Product number: API0045939
Product name: PSEUDOERYTHROMYCIN A ENOL ETHER
Purity: 95.00%
Packaging: 5MG
Price: $503.15
Updated: 2021/12/16

More

Less

LY 267108 Chemical Properties,Usage,Production

Chemical Properties

White Solid

Uses

Pseudo Erythromycin A Enol Ether (Erythromycin EP Impurity F) is an Erythromycin impurity.

Uses

Erythromycin impurity.

Uses

Pseudoerythromycin A enol ether is a degradation product of erythromycin formed by a complex internal rearrangement of erythromycin A on exposure to neutral to weakly alkaline conditions. The C6–OH forms an internal enol ether with the C9 ketone of erythromycin, while the C11-OH attacks the carbonyl of the lactone to reduce the macrocycle from a 14- to an 11-membered macrolide. Synthetically, pseudoerythromycin A enol ether is prepared by reacting erythromycin enol ether with carbonate. Pseudoerythromycin A enol ether is devoid of antibiotic activity but is an important analytical standard for erythromycin A stability studies.

LY 267108 Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

LY 267108 Suppliers

Canada 1 China 53 India 10 Switzerland 1 United Kingdom 1 United States 8 Global 74

Toronto Research Chemicals

Tel: --
Fax: --
Email: info@trc-canada.com
Country: Canada
ProdList: 6038
Advantage: 71

105882-69-7, LY 267108Related Search:

Erythromycin, N-oxide 3'-Demethyl-12-deoxyerythromycin erythralosamine Erythromycin EP Impurity L Erythromycin ethylsuccinate N-DEMETHYL ERYTHROMYCIN A 16-Hydroxyerythromycin erythronolide B LY 267108

LY 267108

(2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-Dideoxy-3-C-Methyl-3-O-Methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-Methylbutyl]-2,6,8,10,12-pentaMethyl-9-[[3,4,6-trideoxy-3-(diMethylaMino)-β-D-xylo-hexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-12-en-5-one

8,9-Anhydropseudo-erythroMycin A-6,9-heMiketal

(2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-12-en-5-one

NMIWBQUQCOMGHJ-XWVSLMRSSA-N

Erythromycin EP Impurity F/(2R,3R,6R,7S,8S,9R,10R)-3-((2R,3R)-2,3-dihydroxypentan-2-yl)-9-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2,6

Erythromycin Impurit F:(pseudoerythromycin A enol ether)

Erythromycin Impurity 15(Erythromycin EP Impurity F)

Erythromycin Ethyl succinate Impurity F

4,13-Dioxabicyclo[8.2.1]tridec-12-en-5-one, 7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, (2R,3R,6R,7S,8S,9R,10R)-

Erythromycin Imp F

Erythromycin EP Impurity F (Pseudo Erythromycin A Enol Ether)

Erythromycin impurity 06

Pseudo erythromycin A enol ether, EvoPure

(2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D- xylohexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-1(12)-en-5- one

105882-69-7

Intermediates & Fine Chemicals

Metabolites & Impurities

Pharmaceuticals

Chromatography

Drugs&Metabolites

Forensic and Veterinary Standards

Neat CompoundsAnalytical Standards

Pharmacology Standards